ACADIA Pharmaceuticals Inc. |
ACAD |
Agios Pharmaceuticals, Inc. |
AGIO |
Alkermes Plc |
ALKS |
Alnylam Pharmaceuticals, Inc. |
ALNY |
Amgen Inc. |
AMGN |
Biogen Inc. |
BIIB |
BioMarin Pharmaceutical Inc. |
BMRN |
BioNTech SE (ADR) |
BNTX |
Bio-Techne Corporation |
TECH |
Charles River Laboratories International, Inc. |
CRL |
Exact Sciences Corporation |
EXAS |
Exelixis, Inc. |
EXEL |
FibroGen, Inc. |
FGEN |
Genmab A/S (ADR) |
GMAB |
Gilead Sciences, Inc. |
GILD |
Grifols, S.A. (ADR) |
GRFS |
Illumina, Inc. |
ILMN |
Incyte Corporation |
INCY |
Ionis Pharmaceuticals, Inc. |
IONS |
IQVIA Holdings Inc. |
IQV |
Mettler-Toledo International Inc. |
MTD |
Moderna, Inc. |
MRNA |
Neurocrine Biosciences, Inc. |
NBIX |
QIAGEN N.V. |
QGEN |
Regeneron Pharmaceuticals, Inc. |
REGN |
Sarepta Therapeutics, Inc. |
SRPT |
Seagen Inc. |
SGEN |
Ultragenyx Pharmaceutical Inc. |
RARE |
United Therapeutics Corporation |
UTHR |
Vertex Pharmaceuticals Incorporated |
VRTX |